![Frontiers | Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis Frontiers | Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis](https://www.frontiersin.org/files/Articles/338078/fneur-09-00218-HTML/image_m/fneur-09-00218-g001.jpg)
Frontiers | Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis
![IJMS | Free Full-Text | Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis IJMS | Free Full-Text | Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis](https://pub.mdpi-res.com/ijms/ijms-21-03419/article_deploy/html/images/ijms-21-03419-ag-550.jpg?1591369073)
IJMS | Free Full-Text | Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
![Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice - ScienceDirect Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001622002489-fx1.jpg)
Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice - ScienceDirect
![Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration - ScienceDirect Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213671123001042-fx1.jpg)
Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration - ScienceDirect
![IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model](https://pub.mdpi-res.com/ijms/ijms-22-10649/article_deploy/html/images/ijms-22-10649-ag.png?1634438729)
IJMS | Free Full-Text | Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
![Opinion: more mouse models and more translation needed for ALS | Molecular Neurodegeneration | Full Text Opinion: more mouse models and more translation needed for ALS | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-023-00619-2/MediaObjects/13024_2023_619_Fig1_HTML.png)
Opinion: more mouse models and more translation needed for ALS | Molecular Neurodegeneration | Full Text
![AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/3b365057-92c6-4519-a160-716214c5694a/fx1_lrg.jpg)
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS: Molecular Therapy - Methods & Clinical Development
![Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model](https://pub.mdpi-res.com/molecules/molecules-26-01590/article_deploy/html/images/molecules-26-01590-ag.png?1615861404)
Molecules | Free Full-Text | A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
![Figure 4 from Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. | Semantic Scholar Figure 4 from Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e507a7d0797d220d9c7305f4d62ed33899cef525/7-Figure4-1.png)
Figure 4 from Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies. | Semantic Scholar
![Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London](https://www.ucl.ac.uk/ion/sites/ion/files/styles/large_image/public/graph_abstract_revised1.jpg?itok=cWnBiFcY)
Humanising mice to enable modelling of neurodegenerative diseases | UCL Queen Square Institute of Neurology - UCL – University College London
![November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC) November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC)](https://mus.brc.riken.jp/en/wp-content/uploads/2015/11/201511.png)
November 2015 Pathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2 | Experimental Animal Division (RIKEN BRC)
![Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia](https://www.frontiersin.org/files/Articles/273825/fncel-11-00196-HTML/image_m/fncel-11-00196-g001.jpg)
Frontiers | Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
![Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3c9acec98cb1a0a0060bc2ed4086c6191c3fdf28/32-Figure3.1-1.png)
Figure 3.1 from The neuromuscular transmission of the SOD 1 ( G 93 A ) mouse model of Amyotrophic Lateral Sclerosis | Semantic Scholar
![Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS | Journal of Neuroinflammation | Full Text Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-019-1598-x/MediaObjects/12974_2019_1598_Fig1_HTML.png)